BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38397058)

  • 1. Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers-A Systematic Review.
    Ciocan RA; Ciocan A; Mihăileanu FV; Ursu CP; Ursu Ș; Bodea C; Cordoș AA; Chiș BA; Al Hajjar N; Dîrzu N; Dîrzu DS
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in Locally Advanced Rectal Cancer: A Review.
    Mendis S; To YH; Tie J
    Clin Colorectal Cancer; 2022 Mar; 21(1):36-44. PubMed ID: 34961731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 5. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer.
    Conde-Muíño R; Cuadros M; Zambudio N; Segura-Jiménez I; Cano C; Palma P
    Biomed Res Int; 2015; 2015():921435. PubMed ID: 26504848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive biomarkers in radioresistant rectal cancer: A systematic review.
    Slipsager A; Henrichsen SN; Falkmer UG; Dybkær K; Belting M; Poulsen LØ
    Crit Rev Oncol Hematol; 2023 Jun; 186():103991. PubMed ID: 37059272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
    Kheirelseid EA; Miller N; Chang KH; Curran C; Hennessey E; Sheehan M; Newell J; Lemetre C; Balls G; Kerin MJ
    Int J Colorectal Dis; 2013 Feb; 28(2):247-60. PubMed ID: 22903298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
    Fan J; Zhu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer.
    Benzoni E; Terrosu G; Intersimone D; Milan E; Chiaulon G; Bresadola V; Sacco C; Sattin E; Bresadola F; Avellini C
    Int J Colorectal Dis; 2007 Jan; 22(1):7-13. PubMed ID: 16538492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer.
    Chen Y; Yang B; Chen M; Li Z; Liao Z
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):201. PubMed ID: 35866399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
    Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer.
    Veen T; Kanani A; Lea D; Søreide K
    Cancer Immunol Immunother; 2023 Oct; 72(10):3135-3147. PubMed ID: 37528319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
    Sauer J; Sobolewski K; Dommisch K
    Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment.
    Kunigenas L; Stankevicius V; Dulskas A; Budginaite E; Alzbutas G; Stratilatovas E; Cordes N; Suziedelis K
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Daniel ES; Gibbs P; Guerrieri M; Faragher I
    Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer.
    Steinhagen E; Shia J; Riedel E; Nash GM; Weiser MR; Temple LK; Paty PB; Guillem JG
    Dis Colon Rectum; 2013 Jan; 56(1):58-63. PubMed ID: 23222281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal Organization as a Predictive Biomarker of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Wang A; Zhang J; Tan C; Lv H; Jin K; Hu Z; Zhou H
    J Gastrointest Surg; 2021 Aug; 25(8):2116-2118. PubMed ID: 33547581
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.